About Remidex Pharma
Remidex Pharma is a Healthcare company based in Bengaluru (India) founded in 1981 by Dayanand S Rao, and was acquired by Jubilant Ingrevia in March 2026. It manufactures high-quality pharmaceutical and nutraceutical products, including tablets, capsules, liquids, and premixes. It operates on a B2B model. The company has 123 employees. Its Indian entity Remidex Pharma Private Limited reported revenue of ₹24.55 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Nutraceutical Production. Its competitors include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed competitors have raised funding.
Company details
Remidex Pharma manufactures high-quality pharmaceutical and nutraceutical products, including tablets, capsules, liquids, and premixes, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and nutraceutical production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Bengaluru, India
- Employees 123
- Founders Dayanand S Rao
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website remidexpharma.com
- Social LinkedIn
- Acquired by Jubilant Ingrevia (Mar 2026)
- Legal Name Remidex Pharma Private Limited
- Date of Incorporation 15 Jun, 1981
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹24.55 Cr
FY 2025 · -22% YoY
- Net Loss-₹1.34 Cr
FY 2025 · -5% margin
- EBITDA-₹3.6 Lakh
FY 2025 · 0% margin
- Investors
- Employee Count123
- Acquired byJubilant Ingrevia
(Mar 2026)
Associated legal entities of Remidex Pharma
Remidex Pharma is associated with 2 registered companies on The Company Check; the primary company is Remidex Pharma Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Remidex Pharma Private Limited CIN U24231KA1981PTC004260 | Active | 15 Jun 1981 | Bengaluru, Karnataka | ₹24.6 Cr | 123 | 3 | View details |
| Remedex Pharma Private Limited CIN U74999KL2016PTC047213 | Active | 07 Nov 2016 | Thiruvananthapuram, Kerala | ₹11.4 Cr | 3 | View details |
Investors in Remidex Pharma
Remidex Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Jubilant Ingrevia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Key ingredients for health and nutrition solutions are manufactured. | 2021 | jubilantingrevia.com | Noida, India |
Investor details for Remidex Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Remidex Pharma Private Limited (Remidex Pharma)
Remidex Pharma Private Limited is the primary company behind Remidex Pharma. The boards of the 2 registered companies of Remidex Pharma currently have 6 directors; the longest-serving is Salman Mohammed Siddikh, appointed in 2016. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Salman Mohammed Siddikh DIN 07460287 | Managing Director | 07 Nov 2016 | 9 yrs 11 mo | Remedex Pharma Private Limited |
| Nilima Dayanand Rao DIN 00737692 | Managing Director | 24 Jan 2017 | 9 yrs 9 mo | Remidex Pharma Private Limited |
| Ishaan Pejavar Rao DIN 08262033 | Director | 24 Oct 2018 | 8 yrs | Remidex Pharma Private Limited |
| Nandan Pejavar Rao DIN 08262013 | Director | 24 Oct 2018 | 8 yrs | Remidex Pharma Private Limited |
| Aleemkhan Nisarudeen DIN 08607346 | Director | 13 Nov 2019 | 6 yrs 11 mo | Remedex Pharma Private Limited |
| Shibin Lal Babu Kamalabai DIN 09299237 | Director | 23 Aug 2021 | 5 yrs 2 mo | Remedex Pharma Private Limited |
People of Remidex Pharma
1 people are tracked at Remidex Pharma (1 in leadership); the tracked headcount is 123.
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for Remidex Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Remidex Pharma
Figures of Remidex Pharma Private Limited, the primary company behind Remidex Pharma, for FY 2025. Revenue was ₹24.55 Cr (-22% year on year). Net loss was -₹1.34 Cr (-5% margin). EBITDA was -₹3.6 Lakh (0% margin). Revenue has grown at a compounded annual rate of +11% over three years and -8% over five years.
- ₹24.55 CrRevenue · FY 2025 · -22% YoY
- -₹1.34 CrNet loss · -5% margin
- -₹3.6 LakhEBITDA · 0% margin
- ₹3.00 CrPaid-up capital
- 123Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- -8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Remidex Pharma Private Limited are on its company page.
Detailed financial statements for Remidex Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Remidex Pharma
2 dated milestones of Remidex Pharma across 45 years, from founding to its latest funding, stage changes and deals.
- Founded Remidex Pharma is founded.
- Exit Acquired by Jubilant Ingrevia.
Competitors of Remidex Pharma
Remidex Pharma has 3 listed competitors in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed competitors of Remidex Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Remidex Pharma
Remidex Pharma was founded in 1981.
Remidex Pharma is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Remidex Pharma has 123 employees.
The primary company behind Remidex Pharma, Remidex Pharma Private Limited, reported revenue of ₹24.55 Cr for FY 2025, down 22% year on year.
Remidex Pharma manufactures high-quality pharmaceutical and nutraceutical products, including tablets, capsules, liquids, and premixes, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and nutraceutical production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Remidex Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Remidex Pharma has 1 investor. Key investors include Jubilant Ingrevia.
Remidex Pharma is associated with 2 legal entities: Remidex Pharma Private Limited, Remedex Pharma Private Limited.
Yes. Remidex Pharma was acquired by Jubilant Ingrevia in March 2026.
The legal entities of Remidex Pharma currently have 6 directors, including Ishaan Pejavar Rao, Nandan Pejavar Rao, Nilima Dayanand Rao and others.